A
Akebia Therapeutics, Inc. (AKBA)
NCM – Real vaqt narxi. Valyuta: USD
1.18
+0.03 (2.61%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
1.18
+0.03 (2.61%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Akebia Therapeutics, Inc., bir biofarmatsevtika kompaniyasi, buyrak kasalliklari bilan og'rigan bemorlar uchun terapevtik vositalarni ishlab chiqish va tijoratlashtirishga qaratilgan. Uning mahsulot portfeliga Vafseo (vadadustat), og'iz orqali yuboriladigan gipoksiya bilan bog'liq omil prolyl gidroksilaza inhibitori, surunkali buyrak kasalligi (SBK) tufayli yuzaga keladigan anemiyani davolash uchun dializga bog'liq (DB) va dializga bog'liq bo'lmagan (DBB) bemorlarda; va Auryxia, kattalar DB-SBK bemorlarida qon zardobidagi fosfor darajasini nazorat qilish va kattalar DBB-SBK bemorlarida temir tanqisligi anemiyasini davolash uchun ishlatiladigan temir sitrati kiradi. Kompaniya, shuningdek, yurak jarrohligi bilan bog'liq o'tkir buyrak shikastlanishi va o'tkir respirator distress sindromini davolash uchun 2-bosqich klinik sinovida bo'lgan AKB-9090; va chaqaloqlarda prematur retinopatiyasini davolash uchun AKB-10108ni ishlab chiqmoqda. Kompaniya Yaponiyada va boshqa Osiyo mamlakatlarida Vafseo-ni ishlab chiqish va tijoratlashtirish bo'yicha Tanabe Pharma Corporation bilan litsenziya va hamkorlik shartnomalariga ega; Vafseo Litsenziya va Hamkorlik Shartnomalari; CSL Vifor Shartnomalari; Averoa Litsenziya Shartnomasi; Panion & BF Biotech, Inc. bilan Litsenziya Shartnomasi; Cyclerion Therapeutics Litsenziya Shartnomasi; va Q32 Aktivlarni Sotib Olish Shartnomasi. Akebia Therapeutics, Inc. 2007 yilda tashkil etilgan va shtab-kvartirasi Kembrij, Massachusetsda joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Justin McCue Ph.D. | Senior VP & Chief Technology Officer |
| Dr. Steven Keith Burke M.D. | Senior VP and Chief Research & Development Officer |
| Mercedes Carrasco | Senior Director of Investor & Corporate Communications |
| Mr. Erik John Ostrowski M.B.A. | Chief Business Officer, Senior VP, CFO & Treasurer |
| Mr. John P. Butler MBA | CEO, President & Director |
| Mr. Nicholas Grund | Senior VP & Chief Commercial Officer |
| Mr. Richard C. Malabre | Senior VP & Chief Accounting Officer |
| Ms. Carolyn M. Rucci | Senior VP, Chief Legal Officer & Secretary |
| Ms. Meredith Bowman | Senior VP & Chief People Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-07 | 8-K | akba-20260507.htm |
| 2026-05-07 | 10-Q | akba-20260331.htm |
| 2026-04-29 | ARS | ef20071767_ars.pdf |
| 2026-04-28 | DEFA14A | a2026defa14a.htm |
| 2026-04-15 | PRE 14A | akba-20260415.htm |
| 2026-04-01 | 8-K | akba-20260327.htm |
| 2026-02-26 | 8-K | akba-20260226.htm |
| 2026-02-26 | 10-K | akba-20251231.htm |
| 2026-01-30 | 8-K | akba-20260127.htm |
| 2026-01-12 | 8-K | akba-20260112.htm |